Chlorine in PDB 8wkg: Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis

Enzymatic activity of Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis

All present enzymatic activity of Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis:
3.1.4.35;

Protein crystallography data

The structure of Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis, PDB code: 8wkg was solved by F.C.Zhang, Y.Y.Huang, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 24.27 / 2.40
Space group P 31 2 1
Cell size a, b, c (Å), α, β, γ (°) 74.09, 74.09, 131.084, 90, 90, 120
R / Rfree (%) 18.6 / 23.5

Other elements in 8wkg:

The structure of Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis also contains other interesting chemical elements:

Magnesium (Mg) 1 atom
Zinc (Zn) 1 atom

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis (pdb code 8wkg). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis, PDB code: 8wkg:

Chlorine binding site 1 out of 1 in 8wkg

Go back to Chlorine Binding Sites List in 8wkg
Chlorine binding site 1 out of 1 in the Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl901

b:59.6
occ:1.00
 CL A:WDB901 0.0 59.6 1.0
C14 A:WDB901 1.7 55.5 1.0
C15 A:WDB901 2.7 51.7 1.0
C13 A:WDB901 2.7 49.6 1.0
CE A:MET816 3.5 65.2 1.0
CB A:ALA783 3.8 44.0 1.0
CG1 A:ILE813 3.8 60.5 1.0
CA A:ALA783 3.9 46.1 1.0
C12 A:WDB901 4.0 49.3 1.0
C10 A:WDB901 4.0 48.8 1.0
CE2 A:PHE787 4.0 62.9 1.0
N A:ALA783 4.1 49.4 1.0
CG2 A:ILE813 4.1 44.6 1.0
CG1 A:VAL782 4.3 33.7 1.0
CD1 A:ILE813 4.4 56.7 1.0
CB A:ILE813 4.4 54.8 1.0
O A:ALA779 4.4 44.3 1.0
C11 A:WDB901 4.5 50.6 1.0
SD A:MET816 4.5 65.2 1.0
OE1 A:GLN817 4.5 43.0 1.0
C A:VAL782 4.6 48.3 1.0
CA A:ILE813 4.8 54.2 1.0
CD2 A:PHE787 4.8 62.1 1.0
CZ A:PHE787 4.9 68.5 1.0
CB A:VAL782 4.9 38.4 1.0
O A:VAL782 4.9 47.8 1.0

Reference:

F.C.Zhang, Y.Y.Huang, H.B.Luo, Y.N.Wu. Rational Design of Highly Selective PDE5 Inhibitors For the Treatment of Idiopathic Pulmonary Fibrosis To Be Published.
Page generated: Thu Oct 31 18:07:27 2024

Last articles

Zn in 9J0N
Zn in 9J0O
Zn in 9J0P
Zn in 9FJX
Zn in 9EKB
Zn in 9C0F
Zn in 9CAH
Zn in 9CH0
Zn in 9CH3
Zn in 9CH1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy